Print

University of Texas MD Anderson Cancer Center Selects MedQuist Speech and Natural Language Understanding Platform for Enterprise-level Deployment  
9/22/2011 9:52:27 AM

FRANKLIN, Tenn., Sept. 22, 2011 (GLOBE NEWSWIRE) -- MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, announced today that The University of Texas MD Anderson Cancer Center of Houston, Texas, has selected the company's cloud-based Speech Understanding™ and Natural Language Understanding (NLU) platform from M*Modal to become an integral part of MD Anderson's proprietary ClinicStation electronic medical record (EMR) system and RadStation radiology solution.
//-->